Lavrov comments on Syrian de-escalation zone agreementRussian Politics & Diplomacy July 24, 20:15
Iraq calls for closer cooperation with RussiaWorld July 24, 19:09
Russia develops laser-guided automatic landing system for dronesMilitary & Defense July 24, 18:22
Communist propaganda ban not aiming to dismantle Soviet WWII memorials, vows Polish envoyWorld July 24, 18:16
Situation with Siemens won’t affect Russian companies — energy ministerBusiness & Economy July 24, 18:11
Russian energy minister says oil prices may grow in 2017Business & Economy July 24, 17:31
Putin fills in Normandy Four on Russia’s approaches to key Minsk accord provisionsRussian Politics & Diplomacy July 24, 16:57
Normandy Four leaders call for ceasefire in DonbassWorld July 24, 16:29
Archstoyanie: Russia's largest land art festivalSociety & Culture July 24, 16:08
BRUSSELS, August 24 (Itar-Tass) - Some 3,600 people with neurotoxic symptoms have contacted hospitals supported by the international medical humanitarian organisation Doctors Without Borders / Medecins Sans Frontieres (MSF) in Syria.
MSF said the hospitals had received all those people in less than three hours on the morning of Wednesday, August 21, 2013. Of those patients, 355 reportedly died.
“Medical staff working in these facilities provided detailed information to MSF doctors regarding large numbers of patients arriving with symptoms including convulsions, excess saliva, pinpoint pupils, blurred vision and respiratory distress,” Bart Janssens, MSF director of operations, said.
Patients were treated using MSF-supplied atropine, a drug used to treat neurotoxic symptoms. MSF is now trying to replenish the facilities’ empty stocks and provide additional medical supplies and guidance, the organisation said.
“MSF can neither scientifically confirm the cause of these symptoms nor establish who is responsible for the attack,” Janssens said. “However, the reported symptoms of the patients, in addition to the epidemiological pattern of the events—characterised by the massive influx of patients in a short period of time, the origin of the patients, and the contamination of medical and first aid workers—strongly indicate mass exposure to a neurotoxic agent. This would constitute a violation of international humanitarian law, which absolutely prohibits the use of chemical and biological weapons.”
Christopher Stokes, MSF general director, said “MSF hopes that independent investigators will be given immediate access to shed light on what happened. This latest attack and subsequent massive medical need come on top of an already catastrophic humanitarian situation, characterised by extreme violence, displacement, and deliberate destruction of medical facilities. In the case of such extreme violations of humanitarian law, humanitarian assistance cannot respond effectively and becomes meaningless itself.”
MSF provides medical assistance in Syria through two different approaches. MSF international and national staff operate six hospitals and four health centres in structures fully under the organisation’s direct control in the north of Syria. In areas where MSF cannot send its own teams because of insecurity or lack of access, the organisation has expanded a program begun two years ago of supporting Syrian medical networks, hospitals and medical posts, by providing drugs, medical equipment, and technical advice and support. Through the latter program, MSF has been supporting 27 hospitals and 56 medical posts throughout Syria.
From June 2012 through the end of June 2013, MSF teams carried out more than 55,000 medical consultations, 2,800 surgical procedures, and assisted in 1,000 births inside Syria. MSF teams have also provided more than 140,000 consultations for Syrian refugees in neighbouring countries, MSF said.
The Syrian government said the opposition had shelled the outskirts of Damascus using ammunition with toxic agents. However, the opposition put all the blame for the attack on government troops.